News

The regulatory path for virtual studies is nebulous and potentially difficult to navigate-finding a way forward requires a thorough understanding of the terrain and how to apply existing legal frameworks.

Higher screen failure and patient dropout rates are raising the imperative to pilot and implement new study conduct models in trial recruitment and retention.

Patrick Jordan, Chief Executive Officer of Mycovia, discusses the company's strategies on tackling Recurrent Vulvovaginal Candidiasis.

Pharmaceutical companies should consider implementing a structured, semi-automated process for intake of compassionate use requests. says ViiV Healthcare executives.

While the future of the industry is still uncertain, a slew of uplifting ideas around innovation could help turn things around.

All of the latest happenings in the industry, all in one place.

Insights from a roundtable at Halloran’s Clinical Operations Retreat for Executives covering major topics in both clinical design and execution.